Speakers

CEO Michael Weickert, PhD, has been developing drugs, devices, and startups for 31 years. Five times startup CEO who has navigated startup companies into clinical development and on to Phase 2 in oncology and anti-infectives. C-level roles in 7 additional startups. Set up an anti-infectives business unit and ran product development, portfolio management and new product planning at Nektar. Obtained Orphan and Fast Track for oncology and anti-infective products. PhD from the U. of Wisconsin, postdoc at NIH/NCI.